source
- Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechsWhen Axiom's stem cell therapy demonstrated a 0% mortality rate over two years in potentially fatal newborn neurological diseases this week, the biotech's leadership saw a broader validation for th…Fierce Biotech · 15d ago↗ source
- I&I startup Attovia files to go public as biotech listings momentum buildsThe tally of biotechs waiting to list in the coming weeks has increased to three, as biologics maker Attovia Therapeutics filed for an initial public offering on Tuesday after the market closed. At…Endpoints · 15d ago↗ source
- Early Alert: Ventilator Issue from ResmedFailure of an electrical component in certain Astral ventilators may cause an interruption or failure in therapy which may result in serious injury or death